Tower Research Capital (TRC)’s Crescent Capital BDC CCAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-16
Closed -$308 5253
2024
Q4
$308 Sell
16
-273
-94% -$5.16K ﹤0.01% 5333
2024
Q3
$5.35K Buy
289
+59
+26% +$1.1K ﹤0.01% 4288
2024
Q2
$4.32K Buy
+230
New +$4.11K ﹤0.01% 4791
2023
Q2
Sell
-3,391
Closed -$46K 6059
2023
Q1
$46K Buy
3,391
+2,704
+394% +$39.2K ﹤0.01% 2560
2022
Q4
$9K Buy
+687
New +$9.32K ﹤0.01% 4167
2022
Q1
Sell
-754
Closed -$13K 6118
2021
Q4
$13K Buy
+754
New +$14.5K ﹤0.01% 4156
2021
Q3
Sell
-20
Closed 5792
2021
Q2
$0 Sell
20
-465
-96% -$8.62K ﹤0.01% 5493
2021
Q1
$8K Sell
485
-1,407
-74% -$22.9K ﹤0.01% 4459
2020
Q4
$27K Buy
1,892
+264
+16% +$3.62K ﹤0.01% 3645
2020
Q3
$21K Sell
1,628
-1,595
-49% -$20K ﹤0.01% 3845
2020
Q2
$41K Sell
3,223
-3,534
-52% -$40.7K ﹤0.01% 3197
2020
Q1
$65K Buy
+6,757
New +$93.3K ﹤0.01% 1167

Other funds holding CCAP

Tower Research Capital (TRC)'s CCAP Position: Q1 2025 in Review

Tower Research Capital (TRC) sold out of Crescent Capital BDC (CCAP) in Q1 2025, closing a stake of 16 shares — an estimated $308 sold.

Tower Research Capital (TRC) first reported a position in CCAP in Q1 2020 and held it in 12 quarters. The position peaked at $65K in Q1 2020. 88 funds tracked by Wall St. Rank hold CCAP as of Q1 2025.

  • Tower Research Capital (TRC) reported no remaining Crescent Capital BDC position as of Q1 2025 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 16 Crescent Capital BDC shares in Q1 2025, an estimated $308.
  • Tower Research Capital (TRC) first reported a position in Crescent Capital BDC in Q1 2020 and held it in 12 quarters.
  • Tower Research Capital (TRC)'s Crescent Capital BDC position peaked at $65K in Q1 2020.
  • 88 funds tracked by Wall St. Rank held Crescent Capital BDC as of Q1 2025.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2025, filed 15 May 2025.